Prodesse Products Help Gen-Probe's Q3 Revenues Rise 8 Percent

The company said that its clinical diagnostics sales growth was driven by a number of factors, including real-time PCR assays from its Prodesse subsidiary, which it acquired last year. Gen-Probe did not break out sales for the Prodesse group, however.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.